Michael Salinger, MD, FACC, FSCAI
- Heart and Vascular Center - Froedtert Hospital
- 9200 West Wisconsin Avenue
- Milwaukee, WI 53226
New & Established Patients Call
I believe in providing outstanding, individualized, compassionate patient care. This requires using the most current technology in a team based fashion guided by advanced clinical research.
Diseases and Conditions
- Coronary Artery Disease
- Hypertrophic Cardiomyopathy
- Mitral Valve Disease
- Patent Foramen Ovale (PFO)
- Atrial Septal Defect
- Structural Heart Disease
- Aortic Stenosis
- Acute Myocardial Infarction
- Paravalvular Leak
Treatments and Services
- Complex PCI
- Impella Supported PCI
- Rotational Atherectomy
- Orbital Atherectomy
- Watchman Left Atrial Appendage Occlusion
- Transcatheter Mitral Valve Repair-MitraClip (TMVr)
- Alcohol Septal Ablation
Patients Ages Seen
- Froedtert Hospital – Milwaukee
- Community Memorial Hospital – Menomonee Falls
- Interventional Cardiology
- Cardiovascular Disease
- Critical Care Medicine
- Internal Medicine
Dr. Salinger is an accomplished interventionalist with more than 10,000 lifetime coronary procedures completed. In addition, Dr. Salinger is an accomplished researcher, having devoted much of his career to advancing the treatment of structural heart disease. Throughout his career he has been involved as an investigator in many national studies, including those for TAVR, MitraClip, PFO/ASD and Watchman. He was part of implant team for the first Lotus Valve and the first MitraClip in the United States.
Education and Training
Doctor of Medicine - Loyola University Chicago, Stritch School of Medicine - Maywood, IL (1979)
Fellowship in Interventional Cardiology - Cleveland Clinic Foundation - Cleveland, OH (1985-1986)
Fellowships in Cardiology and Critical Care Medicine - Northwestern University Medical School - Chicago, IL (1984-1985)
Residency in Internal Medicine - Northwestern University - Evanston, IL (1980-1982)
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
(Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchétché D, Rovin JD, Buchbinder M, Meredith IT, Götberg M, Bjursten H, Meduri C, Salinger MH, Allocco DJ, Dawkins KD.) JAMA. 2018 01 02;319(1):27-37.
(Gajo E, Iftikhar O, Pearson PJ, Feldman T, Guerrero M, Levisay J, Salinger MH.) J Invasive Cardiol. 2017 Aug;29(8):277-279.
(Feldman T, Mehta A, Guerrero M, Levisay JP, Salinger MH.) Interv Cardiol Clin. 2016 01;5(1):83-91.
(Feldman T, Guerrero M, Salinger MH.) EuroIntervention. 2016 Sep 18;12(Y):Y84-9.
(Levisay JP, Sangodkar S, Salinger MH, Lampert M, Feldman T.) J Invasive Cardiol. 2014 Apr;26(4):180-2.
(Feldman T, Salinger MH, Levisay JP, Smart S.) Catheter Cardiovasc Interv. 2014 Feb;83(2):280-8.
(Levisay JP, Salinger MH, Feldman T.) Catheter Cardiovasc Interv. 2014 Apr 01;83(5):824-30.
(Ali O, Salinger MH, Levisay JP, Feldman T.) Catheter Cardiovasc Interv. 2014 Jan 01;83(1):162-8.
(Cilingiroglu M, Feldman T, Salinger MH, Levisay J, Turi ZG.) J Invasive Cardiol. 2011 Apr;23(4):157-61.
(Singh V, Mayer T, Salanitri J, Salinger MH.) Int J Cardiovasc Imaging. 2007 Oct;23(5):591-3.
(Mylonas I, Sakata Y, Salinger MH, Feldman T.) Catheter Cardiovasc Interv. 2006 Apr;67(4):611-6.
(Feldman T, Salinger MH, Das S, Hamilton AJ.) Catheter Cardiovasc Interv. 2006 Jan;67(1):132-8.